Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Tuesday, May 21, 2024 | Back issues
Courthouse News Service Courthouse News Service

Pfizer Wins Challenge |To Two Celebrex Patents

WASHINGTON (CN) - The Federal Circuit ruled for Pfizer on two of three patent claims covering the anti-inflammatory Celebrex that were challenged by the generic drug manufacturer Teva Pharmaceuticals USA. The three-judge panel found that two of the patents were valid, while the third was invalid due to double patenting.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...